Prevalidation of an ELISA for Detection of a New Clinical Entity: Leishmania donovani-Induced Cutaneous Leishmaniasis

Figure 3

The variation of BR and ELISA absorbance values in different concentrations of primary and secondary Ab concentration (P1: high positive serum, P2: low positive serum, and H: healthy serum). (a) Variation of BR. (b) Variation of ELISA absorbance values.

(a)

(b)